View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nivolumab 360 / Paclitaxel 200 / Carboplatin 5, Non-Small Cell Lung Cancer, Neoadjuvant, Cycles 1-3
Protocol-ID: 2387 V1.0 (Mini), NIVO360/PACL200/CRBP5, NSCLC, neoadj., C1-3Indication(s)
- Lung Carcinoma, Non-Small Cell (Stage IIIA/B); ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 04.07.2023